Clinical Trial Update: Paclitaxel in Treating Patients With Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Paclitaxel for lung cancer has completed enrollment/status as reported by EORTC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED